Trial Profile
The effects of switching from lamivudine to telbivudine treatment on renal functions in Liver Transplant recipients for prophylaxis of hepatitis B virus recurrence
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 10 Dec 2015
Price :
$35
*
At a glance
- Drugs Telbivudine (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- 10 Dec 2015 New trial record